My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 227

    1.

    NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.

    Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP).

    Diabetes. 2003 May;52(5):1210-4.PMID: 12716754 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S.

    Hoang KC, Ghandehari H, Lopez VA, Barboza MG, Wong ND.

    Diabetes Care. 2008 Jul;31(7):1405-9. Epub 2008 Mar 28.PMID: 18375418 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

    Onat A, Hergenç G, Sansoy V, Fobker M, Ceyhan K, Toprak S, Assmann G.

    Atherosclerosis. 2003 May;168(1):81-9.PMID: 12732390 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

    Ford ES.

    Diabetes Care. 2005 Nov;28(11):2745-9.PMID: 16249550 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

    Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.PMID: 17420118 [PubMed - indexed for MEDLINE]Related articles

    7.

    Relative importance of borderline and elevated levels of coronary heart disease risk factors.

    Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D'Agostino RB.

    Ann Intern Med. 2005 Mar 15;142(6):393-402. Erratum in: Ann Intern Med. 2005 Apr 19;142(8):681. PMID: 15767617 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.

    Hillier TA, Fosse S, Balkau B, Simon D, Eschwège E, Fagot-Campagna A.

    J Cardiometab Syndr. 2006 Fall;1(5):318-25.PMID: 17679788 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.

    Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J.

    Circulation. 2003 Jul 29;108(4):414-9. Epub 2003 Jul 14.PMID: 12860911 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.

    Ko M, Kim MT, Nam JJ.

    Int J Cardiol. 2006 Jun 16;110(2):184-90. Epub 2006 Jan 18.PMID: 16412525 [PubMed - indexed for MEDLINE]Related articles

    11.

    Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.

    Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM.

    Diabetes Care. 2005 Aug;28(8):1916-21.PMID: 16043732 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.

    Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J; International Diabetes Federation.

    Metabolism. 2007 Apr;56(4):552-8.PMID: 17379016 [PubMed - indexed for MEDLINE]Related articles

    13.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    14.

    Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.

    Lim HS, Lip GY, Beevers DG, Blann AD.

    Eur J Clin Invest. 2005 May;35(5):324-9.PMID: 15860044 [PubMed - indexed for MEDLINE]Related articles

    15.

    The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

    Lorenzo C, Williams K, Hunt KJ, Haffner SM.

    Diabetes Care. 2007 Jan;30(1):8-13.PMID: 17192325 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

    Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V.

    Atherosclerosis. 2002 Dec;165(2):285-92.PMID: 12417279 [PubMed - indexed for MEDLINE]Related articles

    17.

    The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

    Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB.

    Arch Intern Med. 2003 Feb 24;163(4):427-36.PMID: 12588201 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study.

    Taylor H, Liu J, Wilson G, Golden SH, Crook E, Brunson CD, Steffes M, Johnson WD, Sung JH.

    Diabetes Care. 2008 Jun;31(6):1248-53. Epub 2008 Mar 10.PMID: 18332154 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study.

    Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Macchia G, Pagano G.

    Diabetes Metab Res Rev. 2001 Mar-Apr;17(2):124-30.PMID: 11307177 [PubMed - indexed for MEDLINE]Related articles

    20.

    The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.

    Scuteri A, Najjar SS, Morrell CH, Lakatta EG; Cardiovascular Health Study.

    Diabetes Care. 2005 Apr;28(4):882-7.PMID: 15793190 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity